[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Microbial Antimicrobial Peptides Market Growth 2023-2029

March 2023 | 96 pages | ID: G320D8AC5F20EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

LPI (LP Information)' newest research report, the “Microbial Antimicrobial Peptides Industry Forecast” looks at past sales and reviews total world Microbial Antimicrobial Peptides sales in 2022, providing a comprehensive analysis by region and market sector of projected Microbial Antimicrobial Peptides sales for 2023 through 2029. With Microbial Antimicrobial Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbial Antimicrobial Peptides industry.

This Insight Report provides a comprehensive analysis of the global Microbial Antimicrobial Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microbial Antimicrobial Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Microbial Antimicrobial Peptides market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbial Antimicrobial Peptides and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbial Antimicrobial Peptides.

The global Microbial Antimicrobial Peptides market size is projected to grow from US$ 2 million in 2022 to US$ 3 million in 2029; it is expected to grow at a CAGR of 3 from 2023 to 2029.

The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

By region, North America had the highest share of sales, at about 35%.

This report presents a comprehensive overview, market shares, and growth opportunities of Microbial Antimicrobial Peptides market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Bacteria
  • Fungi
Segmentation by application
  • Pharmaceuticals
  • Feed Additives
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • AnaSpec
  • AMP Biotech
  • Phoenix Biotech
  • Novabiotics
  • Chinese Peptide
  • Ontores
Key Questions Addressed in this Report

What is the 10-year outlook for the global Microbial Antimicrobial Peptides market?

What factors are driving Microbial Antimicrobial Peptides market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Microbial Antimicrobial Peptides market opportunities vary by end market size?

How does Microbial Antimicrobial Peptides break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Microbial Antimicrobial Peptides Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Microbial Antimicrobial Peptides by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Microbial Antimicrobial Peptides by Country/Region, 2018, 2022 & 2029
2.2 Microbial Antimicrobial Peptides Segment by Type
  2.2.1 Bacteria
  2.2.2 Fungi
2.3 Microbial Antimicrobial Peptides Sales by Type
  2.3.1 Global Microbial Antimicrobial Peptides Sales Market Share by Type (2018-2023)
  2.3.2 Global Microbial Antimicrobial Peptides Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Microbial Antimicrobial Peptides Sale Price by Type (2018-2023)
2.4 Microbial Antimicrobial Peptides Segment by Application
  2.4.1 Pharmaceuticals
  2.4.2 Feed Additives
  2.4.3 Others
2.5 Microbial Antimicrobial Peptides Sales by Application
  2.5.1 Global Microbial Antimicrobial Peptides Sale Market Share by Application (2018-2023)
  2.5.2 Global Microbial Antimicrobial Peptides Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Microbial Antimicrobial Peptides Sale Price by Application (2018-2023)

3 GLOBAL MICROBIAL ANTIMICROBIAL PEPTIDES BY COMPANY

3.1 Global Microbial Antimicrobial Peptides Breakdown Data by Company
  3.1.1 Global Microbial Antimicrobial Peptides Annual Sales by Company (2018-2023)
  3.1.2 Global Microbial Antimicrobial Peptides Sales Market Share by Company (2018-2023)
3.2 Global Microbial Antimicrobial Peptides Annual Revenue by Company (2018-2023)
  3.2.1 Global Microbial Antimicrobial Peptides Revenue by Company (2018-2023)
  3.2.2 Global Microbial Antimicrobial Peptides Revenue Market Share by Company (2018-2023)
3.3 Global Microbial Antimicrobial Peptides Sale Price by Company
3.4 Key Manufacturers Microbial Antimicrobial Peptides Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Microbial Antimicrobial Peptides Product Location Distribution
  3.4.2 Players Microbial Antimicrobial Peptides Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR MICROBIAL ANTIMICROBIAL PEPTIDES BY GEOGRAPHIC REGION

4.1 World Historic Microbial Antimicrobial Peptides Market Size by Geographic Region (2018-2023)
  4.1.1 Global Microbial Antimicrobial Peptides Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Microbial Antimicrobial Peptides Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Microbial Antimicrobial Peptides Market Size by Country/Region (2018-2023)
  4.2.1 Global Microbial Antimicrobial Peptides Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Microbial Antimicrobial Peptides Annual Revenue by Country/Region (2018-2023)
4.3 Americas Microbial Antimicrobial Peptides Sales Growth
4.4 APAC Microbial Antimicrobial Peptides Sales Growth
4.5 Europe Microbial Antimicrobial Peptides Sales Growth
4.6 Middle East & Africa Microbial Antimicrobial Peptides Sales Growth

5 AMERICAS

5.1 Americas Microbial Antimicrobial Peptides Sales by Country
  5.1.1 Americas Microbial Antimicrobial Peptides Sales by Country (2018-2023)
  5.1.2 Americas Microbial Antimicrobial Peptides Revenue by Country (2018-2023)
5.2 Americas Microbial Antimicrobial Peptides Sales by Type
5.3 Americas Microbial Antimicrobial Peptides Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Microbial Antimicrobial Peptides Sales by Region
  6.1.1 APAC Microbial Antimicrobial Peptides Sales by Region (2018-2023)
  6.1.2 APAC Microbial Antimicrobial Peptides Revenue by Region (2018-2023)
6.2 APAC Microbial Antimicrobial Peptides Sales by Type
6.3 APAC Microbial Antimicrobial Peptides Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Microbial Antimicrobial Peptides by Country
  7.1.1 Europe Microbial Antimicrobial Peptides Sales by Country (2018-2023)
  7.1.2 Europe Microbial Antimicrobial Peptides Revenue by Country (2018-2023)
7.2 Europe Microbial Antimicrobial Peptides Sales by Type
7.3 Europe Microbial Antimicrobial Peptides Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Microbial Antimicrobial Peptides by Country
  8.1.1 Middle East & Africa Microbial Antimicrobial Peptides Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Microbial Antimicrobial Peptides Revenue by Country (2018-2023)
8.2 Middle East & Africa Microbial Antimicrobial Peptides Sales by Type
8.3 Middle East & Africa Microbial Antimicrobial Peptides Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Microbial Antimicrobial Peptides
10.3 Manufacturing Process Analysis of Microbial Antimicrobial Peptides
10.4 Industry Chain Structure of Microbial Antimicrobial Peptides

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Microbial Antimicrobial Peptides Distributors
11.3 Microbial Antimicrobial Peptides Customer

12 WORLD FORECAST REVIEW FOR MICROBIAL ANTIMICROBIAL PEPTIDES BY GEOGRAPHIC REGION

12.1 Global Microbial Antimicrobial Peptides Market Size Forecast by Region
  12.1.1 Global Microbial Antimicrobial Peptides Forecast by Region (2024-2029)
  12.1.2 Global Microbial Antimicrobial Peptides Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Microbial Antimicrobial Peptides Forecast by Type
12.7 Global Microbial Antimicrobial Peptides Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 AnaSpec
  13.1.1 AnaSpec Company Information
  13.1.2 AnaSpec Microbial Antimicrobial Peptides Product Portfolios and Specifications
  13.1.3 AnaSpec Microbial Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 AnaSpec Main Business Overview
  13.1.5 AnaSpec Latest Developments
13.2 AMP Biotech
  13.2.1 AMP Biotech Company Information
  13.2.2 AMP Biotech Microbial Antimicrobial Peptides Product Portfolios and Specifications
  13.2.3 AMP Biotech Microbial Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 AMP Biotech Main Business Overview
  13.2.5 AMP Biotech Latest Developments
13.3 Phoenix Biotech
  13.3.1 Phoenix Biotech Company Information
  13.3.2 Phoenix Biotech Microbial Antimicrobial Peptides Product Portfolios and Specifications
  13.3.3 Phoenix Biotech Microbial Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Phoenix Biotech Main Business Overview
  13.3.5 Phoenix Biotech Latest Developments
13.4 Novabiotics
  13.4.1 Novabiotics Company Information
  13.4.2 Novabiotics Microbial Antimicrobial Peptides Product Portfolios and Specifications
  13.4.3 Novabiotics Microbial Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Novabiotics Main Business Overview
  13.4.5 Novabiotics Latest Developments
13.5 Chinese Peptide
  13.5.1 Chinese Peptide Company Information
  13.5.2 Chinese Peptide Microbial Antimicrobial Peptides Product Portfolios and Specifications
  13.5.3 Chinese Peptide Microbial Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Chinese Peptide Main Business Overview
  13.5.5 Chinese Peptide Latest Developments
13.6 Ontores
  13.6.1 Ontores Company Information
  13.6.2 Ontores Microbial Antimicrobial Peptides Product Portfolios and Specifications
  13.6.3 Ontores Microbial Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Ontores Main Business Overview
  13.6.5 Ontores Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Microbial Antimicrobial Peptides Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Microbial Antimicrobial Peptides Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Bacteria
Table 4. Major Players of Fungi
Table 5. Global Microbial Antimicrobial Peptides Sales by Type (2018-2023) & (Kiloton)
Table 6. Global Microbial Antimicrobial Peptides Sales Market Share by Type (2018-2023)
Table 7. Global Microbial Antimicrobial Peptides Revenue by Type (2018-2023) & ($ million)
Table 8. Global Microbial Antimicrobial Peptides Revenue Market Share by Type (2018-2023)
Table 9. Global Microbial Antimicrobial Peptides Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Microbial Antimicrobial Peptides Sales by Application (2018-2023) & (Kiloton)
Table 11. Global Microbial Antimicrobial Peptides Sales Market Share by Application (2018-2023)
Table 12. Global Microbial Antimicrobial Peptides Revenue by Application (2018-2023)
Table 13. Global Microbial Antimicrobial Peptides Revenue Market Share by Application (2018-2023)
Table 14. Global Microbial Antimicrobial Peptides Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Microbial Antimicrobial Peptides Sales by Company (2018-2023) & (Kiloton)
Table 16. Global Microbial Antimicrobial Peptides Sales Market Share by Company (2018-2023)
Table 17. Global Microbial Antimicrobial Peptides Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Microbial Antimicrobial Peptides Revenue Market Share by Company (2018-2023)
Table 19. Global Microbial Antimicrobial Peptides Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Microbial Antimicrobial Peptides Producing Area Distribution and Sales Area
Table 21. Players Microbial Antimicrobial Peptides Products Offered
Table 22. Microbial Antimicrobial Peptides Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Microbial Antimicrobial Peptides Sales by Geographic Region (2018-2023) & (Kiloton)
Table 26. Global Microbial Antimicrobial Peptides Sales Market Share Geographic Region (2018-2023)
Table 27. Global Microbial Antimicrobial Peptides Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Microbial Antimicrobial Peptides Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Microbial Antimicrobial Peptides Sales by Country/Region (2018-2023) & (Kiloton)
Table 30. Global Microbial Antimicrobial Peptides Sales Market Share by Country/Region (2018-2023)
Table 31. Global Microbial Antimicrobial Peptides Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Microbial Antimicrobial Peptides Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Microbial Antimicrobial Peptides Sales by Country (2018-2023) & (Kiloton)
Table 34. Americas Microbial Antimicrobial Peptides Sales Market Share by Country (2018-2023)
Table 35. Americas Microbial Antimicrobial Peptides Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Microbial Antimicrobial Peptides Revenue Market Share by Country (2018-2023)
Table 37. Americas Microbial Antimicrobial Peptides Sales by Type (2018-2023) & (Kiloton)
Table 38. Americas Microbial Antimicrobial Peptides Sales by Application (2018-2023) & (Kiloton)
Table 39. APAC Microbial Antimicrobial Peptides Sales by Region (2018-2023) & (Kiloton)
Table 40. APAC Microbial Antimicrobial Peptides Sales Market Share by Region (2018-2023)
Table 41. APAC Microbial Antimicrobial Peptides Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Microbial Antimicrobial Peptides Revenue Market Share by Region (2018-2023)
Table 43. APAC Microbial Antimicrobial Peptides Sales by Type (2018-2023) & (Kiloton)
Table 44. APAC Microbial Antimicrobial Peptides Sales by Application (2018-2023) & (Kiloton)
Table 45. Europe Microbial Antimicrobial Peptides Sales by Country (2018-2023) & (Kiloton)
Table 46. Europe Microbial Antimicrobial Peptides Sales Market Share by Country (2018-2023)
Table 47. Europe Microbial Antimicrobial Peptides Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Microbial Antimicrobial Peptides Revenue Market Share by Country (2018-2023)
Table 49. Europe Microbial Antimicrobial Peptides Sales by Type (2018-2023) & (Kiloton)
Table 50. Europe Microbial Antimicrobial Peptides Sales by Application (2018-2023) & (Kiloton)
Table 51. Middle East & Africa Microbial Antimicrobial Peptides Sales by Country (2018-2023) & (Kiloton)
Table 52. Middle East & Africa Microbial Antimicrobial Peptides Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Microbial Antimicrobial Peptides Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Microbial Antimicrobial Peptides Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Microbial Antimicrobial Peptides Sales by Type (2018-2023) & (Kiloton)
Table 56. Middle East & Africa Microbial Antimicrobial Peptides Sales by Application (2018-2023) & (Kiloton)
Table 57. Key Market Drivers & Growth Opportunities of Microbial Antimicrobial Peptides
Table 58. Key Market Challenges & Risks of Microbial Antimicrobial Peptides
Table 59. Key Industry Trends of Microbial Antimicrobial Peptides
Table 60. Microbial Antimicrobial Peptides Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Microbial Antimicrobial Peptides Distributors List
Table 63. Microbial Antimicrobial Peptides Customer List
Table 64. Global Microbial Antimicrobial Peptides Sales Forecast by Region (2024-2029) & (Kiloton)
Table 65. Global Microbial Antimicrobial Peptides Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Microbial Antimicrobial Peptides Sales Forecast by Country (2024-2029) & (Kiloton)
Table 67. Americas Microbial Antimicrobial Peptides Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Microbial Antimicrobial Peptides Sales Forecast by Region (2024-2029) & (Kiloton)
Table 69. APAC Microbial Antimicrobial Peptides Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Microbial Antimicrobial Peptides Sales Forecast by Country (2024-2029) & (Kiloton)
Table 71. Europe Microbial Antimicrobial Peptides Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Microbial Antimicrobial Peptides Sales Forecast by Country (2024-2029) & (Kiloton)
Table 73. Middle East & Africa Microbial Antimicrobial Peptides Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Microbial Antimicrobial Peptides Sales Forecast by Type (2024-2029) & (Kiloton)
Table 75. Global Microbial Antimicrobial Peptides Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Microbial Antimicrobial Peptides Sales Forecast by Application (2024-2029) & (Kiloton)
Table 77. Global Microbial Antimicrobial Peptides Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AnaSpec Basic Information, Microbial Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 79. AnaSpec Microbial Antimicrobial Peptides Product Portfolios and Specifications
Table 80. AnaSpec Microbial Antimicrobial Peptides Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. AnaSpec Main Business
Table 82. AnaSpec Latest Developments
Table 83. AMP Biotech Basic Information, Microbial Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 84. AMP Biotech Microbial Antimicrobial Peptides Product Portfolios and Specifications
Table 85. AMP Biotech Microbial Antimicrobial Peptides Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. AMP Biotech Main Business
Table 87. AMP Biotech Latest Developments
Table 88. Phoenix Biotech Basic Information, Microbial Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 89. Phoenix Biotech Microbial Antimicrobial Peptides Product Portfolios and Specifications
Table 90. Phoenix Biotech Microbial Antimicrobial Peptides Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Phoenix Biotech Main Business
Table 92. Phoenix Biotech Latest Developments
Table 93. Novabiotics Basic Information, Microbial Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 94. Novabiotics Microbial Antimicrobial Peptides Product Portfolios and Specifications
Table 95. Novabiotics Microbial Antimicrobial Peptides Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Novabiotics Main Business
Table 97. Novabiotics Latest Developments
Table 98. Chinese Peptide Basic Information, Microbial Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 99. Chinese Peptide Microbial Antimicrobial Peptides Product Portfolios and Specifications
Table 100. Chinese Peptide Microbial Antimicrobial Peptides Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Chinese Peptide Main Business
Table 102. Chinese Peptide Latest Developments
Table 103. Ontores Basic Information, Microbial Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 104. Ontores Microbial Antimicrobial Peptides Product Portfolios and Specifications
Table 105. Ontores Microbial Antimicrobial Peptides Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Ontores Main Business
Table 107. Ontores Latest Developments

LIST OF FIGURES

Figure 1. Picture of Microbial Antimicrobial Peptides
Figure 2. Microbial Antimicrobial Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Microbial Antimicrobial Peptides Sales Growth Rate 2018-2029 (Kiloton)
Figure 7. Global Microbial Antimicrobial Peptides Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Microbial Antimicrobial Peptides Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Bacteria
Figure 10. Product Picture of Fungi
Figure 11. Global Microbial Antimicrobial Peptides Sales Market Share by Type in 2022
Figure 12. Global Microbial Antimicrobial Peptides Revenue Market Share by Type (2018-2023)
Figure 13. Microbial Antimicrobial Peptides Consumed in Pharmaceuticals
Figure 14. Global Microbial Antimicrobial Peptides Market: Pharmaceuticals (2018-2023) & (Kiloton)
Figure 15. Microbial Antimicrobial Peptides Consumed in Feed Additives
Figure 16. Global Microbial Antimicrobial Peptides Market: Feed Additives (2018-2023) & (Kiloton)
Figure 17. Microbial Antimicrobial Peptides Consumed in Others
Figure 18. Global Microbial Antimicrobial Peptides Market: Others (2018-2023) & (Kiloton)
Figure 19. Global Microbial Antimicrobial Peptides Sales Market Share by Application (2022)
Figure 20. Global Microbial Antimicrobial Peptides Revenue Market Share by Application in 2022
Figure 21. Microbial Antimicrobial Peptides Sales Market by Company in 2022 (Kiloton)
Figure 22. Global Microbial Antimicrobial Peptides Sales Market Share by Company in 2022
Figure 23. Microbial Antimicrobial Peptides Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Microbial Antimicrobial Peptides Revenue Market Share by Company in 2022
Figure 25. Global Microbial Antimicrobial Peptides Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Microbial Antimicrobial Peptides Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Microbial Antimicrobial Peptides Sales 2018-2023 (Kiloton)
Figure 28. Americas Microbial Antimicrobial Peptides Revenue 2018-2023 ($ Millions)
Figure 29. APAC Microbial Antimicrobial Peptides Sales 2018-2023 (Kiloton)
Figure 30. APAC Microbial Antimicrobial Peptides Revenue 2018-2023 ($ Millions)
Figure 31. Europe Microbial Antimicrobial Peptides Sales 2018-2023 (Kiloton)
Figure 32. Europe Microbial Antimicrobial Peptides Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Microbial Antimicrobial Peptides Sales 2018-2023 (Kiloton)
Figure 34. Middle East & Africa Microbial Antimicrobial Peptides Revenue 2018-2023 ($ Millions)
Figure 35. Americas Microbial Antimicrobial Peptides Sales Market Share by Country in 2022
Figure 36. Americas Microbial Antimicrobial Peptides Revenue Market Share by Country in 2022
Figure 37. Americas Microbial Antimicrobial Peptides Sales Market Share by Type (2018-2023)
Figure 38. Americas Microbial Antimicrobial Peptides Sales Market Share by Application (2018-2023)
Figure 39. United States Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Microbial Antimicrobial Peptides Sales Market Share by Region in 2022
Figure 44. APAC Microbial Antimicrobial Peptides Revenue Market Share by Regions in 2022
Figure 45. APAC Microbial Antimicrobial Peptides Sales Market Share by Type (2018-2023)
Figure 46. APAC Microbial Antimicrobial Peptides Sales Market Share by Application (2018-2023)
Figure 47. China Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Microbial Antimicrobial Peptides Sales Market Share by Country in 2022
Figure 55. Europe Microbial Antimicrobial Peptides Revenue Market Share by Country in 2022
Figure 56. Europe Microbial Antimicrobial Peptides Sales Market Share by Type (2018-2023)
Figure 57. Europe Microbial Antimicrobial Peptides Sales Market Share by Application (2018-2023)
Figure 58. Germany Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Microbial Antimicrobial Peptides Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Microbial Antimicrobial Peptides Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Microbial Antimicrobial Peptides Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Microbial Antimicrobial Peptides Sales Market Share by Application (2018-2023)
Figure 67. Egypt Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Microbial Antimicrobial Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Microbial Antimicrobial Peptides in 2022
Figure 73. Manufacturing Process Analysis of Microbial Antimicrobial Peptides
Figure 74. Industry Chain Structure of Microbial Antimicrobial Peptides
Figure 75. Channels of Distribution
Figure 76. Global Microbial Antimicrobial Peptides Sales Market Forecast by Region (2024-2029)
Figure 77. Global Microbial Antimicrobial Peptides Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Microbial Antimicrobial Peptides Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Microbial Antimicrobial Peptides Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Microbial Antimicrobial Peptides Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Microbial Antimicrobial Peptides Revenue Market Share Forecast by Application (2024-2029)


More Publications